Atlas Trials

A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone

Clinical trial NCT00979875 · COMPLETED

Trial details

NCT number
NCT00979875
Sponsor
Halozyme Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2009-09-01
Primary completion
2010-02-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.